Skip to main content
Premium Trial:

Request an Annual Quote

Zyomyx Adds Notch to Patent Belt

NEW YORK, April 2 - Proteomics company Zyomyx said today that it has been granted a second patent by the US Patent and Trademark Office for its protein-chip technology.


The patent, which was granted today, covers surface chemistry configurations and describes a variety of antibody arrays.


In January, the company secured a related patent on protein-chip surface and attachment technology.


Based in Hayward, Calif., Zyomyx is developing high density protein biochips based on a surface chemistry derived from high resolution microscopy. The company, which is privately owned, hopes to develop chips for up to 10,000 different proteins.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.